Literature DB >> 22903454

Minimally invasive surgery for gastric cancer.

Zubin M Bamboat1, Vivian E Strong.   

Abstract

Application of minimally invasive techniques to gastric cancer in the West has been curbed by concerns of feasibility and oncologic adequacy. Growing evidence supports improved short-term and equivalent oncologic outcomes in selected patients undergoing laparoscopic surgery for early-stage disease. Laparoscopic resection for advanced gastric cancer remains controversial due to few reliable studies on long-term outcomes. We focus on important studies from Asia and highlight the Western experience with laparoscopic and robotic surgery for gastric carcinoma.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2012        PMID： 22903454     DOI： 10.1002/jso.23237

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  12 in total

1.  Technical aspects and short- and long-term outcomes of totally laparoscopic total gastrectomy for advanced gastric cancer: a single-institution retrospective study.

Authors:  Masaya Nakauchi; Koichi Suda; Shinichi Kadoya; Kazuki Inaba; Yoshinori Ishida; Ichiro Uyama
Journal:  Surg Endosc       Date:  2015-12-24       Impact factor: 4.584

2.  Feasibility and safety of modified inverted T-shaped method using linear stapler with movable cartridge fork for esophagojejunostomy following laparoscopic total gastrectomy.

Authors:  Kenoki Ohuchida; Eishi Nagai; Taiki Moriyama; Koji Shindo; Tatsuya Manabe; Takao Ohtsuka; Shuji Shimizu; Masafumi Nakamura
Journal:  Transl Gastroenterol Hepatol       Date:  2017-05-23

3.  Case-matched comparison of laparoscopy-assisted and open distal gastrectomy for gastric cancer.

Authors:  Wei Wang; Ke Chen; Xiao-Wu Xu; Yu Pan; Yi-Ping Mou
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

4.  Potential advantages of robotic radical gastrectomy for gastric adenocarcinoma in comparison with conventional laparoscopic approach: a single institutional retrospective comparative cohort study.

Authors:  Koichi Suda; Mariko Man-I; Yoshinori Ishida; Yuichiro Kawamura; Seiji Satoh; Ichiro Uyama
Journal:  Surg Endosc       Date:  2014-07-17       Impact factor: 4.584

Review 5.  Treatment of early gastric cancer in the Western World.

Authors:  Elfriede Bollschweiler; Felix Berlth; Christoph Baltin; Stefan Mönig; Arnulf H Hölscher
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 6.  Totally laparoscopic gastrectomy for gastric cancer: a systematic review and meta-analysis of outcomes compared with open surgery.

Authors:  Ke Chen; Yu Pan; Jia-Qin Cai; Xiao-Wu Xu; Di Wu; Yi-Ping Mou
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

7.  The long-term clinical outcomes of robotic gastrectomy for gastric cancer: a large-scale single institutional retrospective study.

Authors:  Yuxing Jiang; Yongliang Zhao; Feng Qian; Yan Shi; Yingxue Hao; Jun Chen; Pingang Li; Peiwu Yu
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

8.  Laparoscopic subtotal gastrectomy for advanced gastric cancer: technical aspects and surgical, nutritional and oncological outcomes.

Authors:  Masaya Nakauchi; Koichi Suda; Kenichi Nakamura; Susumu Shibasaki; Kenji Kikuchi; Tetsuya Nakamura; Shinichi Kadoya; Yoshinori Ishida; Kazuki Inaba; Keizo Taniguchi; Ichiro Uyama
Journal:  Surg Endosc       Date:  2017-04-07       Impact factor: 4.584

Review 9.  Treatment modalities for early gastric cancer.

Authors:  Jesús Espinel; Eugenia Pinedo; Vanesa Ojeda; Maria Guerra Del Rio
Journal:  World J Gastrointest Endosc       Date:  2015-09-10

10.  Comparison of the long-term outcomes of robotic radical gastrectomy for gastric cancer and conventional laparoscopic approach: a single institutional retrospective cohort study.

Authors:  Masaya Nakauchi; Koichi Suda; Shibasaki Susumu; Shinichi Kadoya; Kazuki Inaba; Yoshinori Ishida; Ichiro Uyama
Journal:  Surg Endosc       Date:  2016-04-29       Impact factor: 4.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.